Results 111 to 120 of about 40,986 (311)
Update on commonly used molecular typing methods for Clostridioides Difficile [PDF]
, 2023 This review aims to provide a comprehensive overview of the significant Clostridioides difficile molecular typing techniques currently employed in research and medical communities.
Abad-Fau, Ana +4 more
core +1 more source
Synthetic Biology‐Based Engineering Living Therapeutics for Antimicrobial Application
Exploration, EarlyView.This perspective highlights synthetic biology‐driven antibacterial strategies, focusing on three innovative approaches: engineered bacteriophages for precision bacterial targeting, reprogrammed microbes that detect quorum‐sensing signals or metabolites to release antimicrobials, and engineering mammalian cells that recognize pathogen‐associated ...
Shun Huang +4 more
wiley +1 more source
Family Medicine & Primary Care ReviewClostridioides difficile infection is the most common cause of antibiotic-associated diarrhea. IDSA/SHEA, ESCMID and ACG updated the clinical practice guidelines for CDI in 2021. This paper is an attempt to summarize these guidelines.
Mateusz Piotr Baran +4 more
doaj +1 more source
Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases [PDF]
, 2023 Clostridioides difficile (C. difficile) is progressively colonizing humans and animals living with humans. During this process, hypervirulent strains and mutated toxin A and B of C. difficile (TcdA and TcdB) are originating and developing.
Bassotti, Gabrio +4 more
core +1 more source
Gut microbiota and tuberculosis
iMeta, EarlyView.This review explores the intricate relationship between gut microbiota (GM) and tuberculosis (TB). The figure illustrates the bidirectional effects between GM dynamics and TB progression, as well as the interactions between the GM and antituberculosis drugs.
Yanhua Liu +39 more
wiley +1 more source
Clostridioides difficile and Gut Microbiota: From Colonization to Infection and Treatment
PathogensClostridioides difficile is the main causative agent of antibiotic-associated diarrhea (AAD) in hospitals in the developed world. Both infected patients and asymptomatic colonized individuals represent important transmission sources of C. difficile.
P. Spigaglia
semanticscholar +1 more source
Fidaxomicin to prevent recurrent Clostridioides difficile: what will it cost in the USA and Canada?
JAC-Antimicrobial Resistance, 2023 Importance Recent changes in guidelines for managing Clostridioides difficile infections (CDI) have placed fidaxomicin as a first-line treatment. Objective To estimate the net cost of first-line fidaxomicin compared to vancomycin in the American and ...
Devangi Patel +7 more
semanticscholar +1 more source
JPGN Reports, EarlyView.Abstract Mesenteric hematomas (MHs) are relatively rare and are characterized by localized bleeding in the mesenteric vascular tree presenting with abdominal pain, vomiting, abdominal distension, masses, and hypotension. We report a case of a MH which was incidentally found in a 10‐year‐old patient with a new diagnosis of ulcerative colitis (UC).
Breanna Brown +2 more
wiley +1 more source
Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis [PDF]
, 2020 Importance: An understanding of the incidence and outcomes of Clostridium difficile infection (CDI) in the United States can inform investments in prevention and treatment interventions.
Balkenende, Erin +15 more
core +1 more source
Expanding Our Grasp of Two-Component Signaling in \u3ci\u3eClostridioides difficile\u3c/i\u3e [PDF]
, 2023 The intestinal pathogen Clostridioides difficile encodes roughly 50 TCS, but very few have been characterized in terms of their activating signals or their regulatory roles. A. G. Pannullo, B. R. Zbylicki, and C. D. Ellermeier (J Bacteriol 205:e00164-23,
Alvarez, Orlando Berumen +1 more
core +1 more source